Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Naltrexone for Bladder Pain Syndrome
NCT04450316Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Stanford University. Started Oct 2020; status: terminated.
02
Drugs
naltrexone
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT04450316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04450316.